Exagen Inc
NASDAQ:XGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Exagen Inc
NASDAQ:XGN
|
US |
|
A
|
Alibaba Health Information Technology Ltd
HKEX:241
|
HK |
|
A
|
Ardmore Shipping Corp
F:A61
|
BM |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
Pembangunan Perumahan (Persero) Tbk PT
IDX:PTPP
|
ID |
|
M
|
Masan Group Corp
VN:MSN
|
VN |
|
Aryzta AG
SIX:ARYN
|
CH |
|
A
|
Adira Dinamika Multi Finance Tbk PT
IDX:ADMF
|
ID |
|
Ardmore Shipping Corp
NYSE:ASC
|
BM |
|
T
|
TenX Protocols Inc
XTSX:TNX
|
CA |
|
I
|
Intel Corp
XHAM:INL
|
US |
|
ExpreS2ion Biotech Holding AB
F:5JD0
|
SE |
|
Gabriel Holding A/S
F:1GH
|
DK |
|
Freehill Mining Ltd
ASX:FHS
|
AU |
|
Aena SME SA
F:A440
|
ES |
|
S
|
Sunrise Communications Ltd
SIX:SUNN
|
CH |
|
Indika Energy Tbk PT
IDX:INDY
|
ID |
|
Lomiko Metals Inc
XTSX:LMR
|
CA |
|
Enwell Energy PLC
LSE:ENW
|
UK |
|
Tokyo Electron Ltd
TSE:8035
|
JP |
|
ContextVision AB
OSE:CONTX
|
SE |
|
BWP Trust
F:GJZ
|
AU |
|
Turning Point Brands Inc
NYSE:TPB
|
US |
|
ExpreS2ion Biotech Holding AB
STO:EXPRS2
|
SE |
Bankruptcy Probability
Exagen Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Exagen Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Exagen Inc
NASDAQ:XGN
|
124m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Exagen Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Exagen Inc has total debt of 23.9m USD. This includes both short-term (0 USD) and long-term (23.9m USD) debt.
You can find a full breakdown on its Balance Sheet.